Contact information
laurent.servais@paediatrics.ox.ac.uk
Fardowsi Kazi
fardowsi.kazi@paediatrics.ox.ac.uk
Laurent Servais
Professor of Paediatric Neuromuscular Diseases, Academic Director of the new Paediatric CRF
Biosketch
I am Professor of Paediatric Neuromuscular Diseases at the MDUK Oxford Neuromuscular Centre and Invited Professor of Child Neurology at Liège University.
After graduating from Louvain Medical School, Brussels, Belgium in 1999, I completed a PhD in Neuroscience (cerebellar electrophysiology in alert living mice) from Free University of Brussels, Belgium, followed by residencies in child neurology at the Free University of Brussels and Robert Debré Hospital, Paris. In 2008, I took a position in neuromuscular disease and clinical research at the Institute of Myology in Paris, where my interest and expertise in neuromuscular diseases flourished. I was subsequently appointed Head of Clinical Trials and Database Services. Most recently, I served as Head of the Institute of Myology’s I-Motion (Institute Of Muscle-Oriented Translational Innovation), and Head of the Neuromuscular Centre in Liège, Belgium. I have joined MD UK Oxford Neuromuscular Center and the University of Oxford in September 2019.
I have been involved as principal investigator in numerous clinical trials to test treatments for Duchenne muscular dystrophy and spinal muscular atrophy (SMA).
I am the leader of the newborn screening program for SMA in southern Belgium where we are conducting a medico-economic analysis of newborn screening. My main research expertise covers the development of innovative outcome measures, including connected devices for real-life patients’ evaluation.
Recent publications
-
Quantitative proteome analysis of LAP1-deficient human fibroblasts: A pilot approach for predicting the signaling pathways deregulated in LAP1-associated diseases
Journal article
Pereira CD. et al, (2024), Biochemistry and Biophysics Reports, 39
-
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients.
Journal article
Mackels L. et al, (2024), International journal of molecular sciences, 25
-
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.
Journal article
Schroth M. et al, (2024), Neurol Clin Pract, 14
-
A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders.
Journal article
Vrellaku B. et al, (2024), Mol Ther
-
Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium.
Journal article
Dangouloff T. et al, (2024), Children (Basel, Switzerland), 11